Citadel Advisors’s Counterpath Corp CPAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12,290
Closed -$14K 10251
2019
Q3
$14K Buy
+12,290
New +$16.3K ﹤0.01% 9013
2019
Q2
Sell
-29,342
Closed -$49K 10364
2019
Q1
$49K Buy
29,342
+18,297
+166% +$28.9K ﹤0.01% 8831
2018
Q4
$13K Buy
+11,045
New +$21.2K ﹤0.01% 8888
2018
Q2
Sell
-12,311
Closed -$35K 9693
2018
Q1
$35K Buy
12,311
+1,918
+18% +$7.52K ﹤0.01% 8016
2017
Q4
$33K Buy
+10,393
New +$26.8K ﹤0.01% 7749
2017
Q3
Sell
-12,276
Closed -$24K 8533
2017
Q2
$24K Buy
+12,276
New +$25.7K ﹤0.01% 7255
2016
Q4
Sell
-10,004
Closed -$20K 8370
2016
Q3
$20K Buy
+10,004
New +$22K ﹤0.01% 7059
2014
Q4
Sell
-1,602
Closed -$15K 8973
2014
Q3
$15K Sell
1,602
-4
-0.2% -$43 ﹤0.01% 7637
2014
Q2
$16K Buy
+1,606
New +$19.8K ﹤0.01% 7432
2014
Q1
Sell
-1,675
Closed -$18K 8206
2013
Q4
$18K Buy
1,675
+338
+25% +$4.43K ﹤0.01% 6533
2013
Q3
$19K Buy
+1,337
New +$21.9K ﹤0.01% 6251

Other funds holding CPAH

Citadel Advisors's CPAH Position: Q4 2019 in Review

Citadel Advisors sold out of Counterpath Corp (CPAH) in Q4 2019, closing a stake of 12,290 shares — an estimated $14K sold.

Citadel Advisors first reported a position in CPAH in Q3 2013 and held it in 11 quarters. The position peaked at $49K in Q1 2019. 8 funds tracked by Wall St. Rank hold CPAH as of Q4 2019.

  • Citadel Advisors reported no remaining Counterpath Corp position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 12,290 Counterpath Corp shares in Q4 2019, an estimated $14K.
  • Citadel Advisors first reported a position in Counterpath Corp in Q3 2013 and held it in 11 quarters.
  • Citadel Advisors's Counterpath Corp position peaked at $49K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Counterpath Corp as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.